RARE DISEASES A–Z · LETTER P
Progressive Supranuclear Palsy
Progressive supranuclear palsy (PSP) is a rare brain disease caused by tau protein damaging movement and balance centres. It is one of the atypical parkinsonian disorders — it resembles Parkinson disease at a glance, but its early falls and its eye movement failure give it away.
By Dr. Mohamed Ibrahim, MD, PhD — Assistant Professor of Medicine, Transplant Nephrology, University of Maryland School of Medicine · Last reviewed: November 2026
Rare Diseases A–Z is part of the MedicalVideos.com education program. It is produced independently of sponsors, and any future sponsorship will be labelled on the hub.
The guide
The basics
PSP damages the basal ganglia, brainstem, and frontal lobes. Its earliest and most disabling feature is postural instability: unexplained falls, typically backwards, within the first year or two — often the clue that this is not ordinary Parkinson disease. Stiffness affects the trunk and neck more than the limbs, producing an upright, extended posture (the opposite of Parkinson's stooped one). The face takes on a startled, staring look with deepened furrows and reduced blinking. Eye movements fail in a characteristic order — slowing of downward gaze first, so reading and descending stairs become hard, then upgaze, then horizontal movements. Speech becomes slow and slurred, swallowing unsafe, and personality changes — apathy, impulsivity, emotional lability — reflect the frontal damage. Tremor is usually absent or mild.
How it works
Diagnosis is clinical, using international criteria built around the four domains: eye movement failure, postural instability, parkinsonism pattern, and cognitive/behavioural change. MRI supports it — midbrain shrinkage produces the 'hummingbird sign' on side-view images, and measurements of midbrain-to-pons ratio help distinguish PSP from Parkinson disease and MSA. Levodopa response is poor or transient, itself a diagnostic pointer. Eye movement examination by an experienced clinician remains the single most informative test — vertical saccades (fast gaze shifts) slow before the range of gaze is lost. There is no blood or spinal fluid test that confirms PSP; biomarkers are a research priority. Atypical variants (PSP-parkinsonism, PSP with predominant frontal features) progress more slowly and are recognised in the criteria.
Day to day
No medicine slows PSP; levodopa is tried and helps a minority modestly. Treatment is therefore a coordinated safety and symptom programme. Falls: physiotherapy for gait and transfers, walking aids chosen for backward instability, home hazard removal, hip protectors, and supervision planning. Swallowing: regular speech-therapy review, diet modification, and timely, informed decisions about tube feeding. Eyes: lubricating drops, botulinum toxin for eyelid spasm or apraxia of eyelid opening in selected cases, and prism or tinted lenses. Mood and apathy are treated actively; sleep disturbance and constipation managed conventionally. As PSP advances, the emphasis shifts to comfort, nutrition, and preventing pneumonia — the usual cause of death — with palliative care supporting patient and family throughout.
When to get help
Care is multidisciplinary: neurology, physiotherapy with falls training, occupational therapy (home safety, weighted walkers — standard frames can tip with backward falls), speech and swallowing therapy, dietetics, neuropsychology, and palliative care for planning. Reviews track falls, swallow safety, weight, mood, and eye comfort (dry eyes from reduced blinking need lubricants; special lenses can help reading). Report choking, chest infections, falls with injury, or rapid decline — usually infection-driven and treatable. Driving must stop early in most cases. Advance care planning, including feeding decisions, is best discussed while communication is still easy; families consistently value having done it early.
Common questions
What does the name mean?
'Supranuclear' describes the lesion's level: the fault is in command centres above the eye-movement nuclei, so the eye's own machinery is intact — reflex movements (the doll's-head manoeuvre) can still move eyes that voluntary gaze cannot. 'Palsy' is the resulting weakness of gaze.
How is PSP different from Parkinson's disease?
PSP typically begins with falls and balance failure rather than tremor, affects the trunk and neck more than the limbs, produces a staring expression with reduced blinking, slows vertical eye movements early, and responds poorly to levodopa. Parkinson disease usually starts asymmetrically in a limb, with tremor, and responds well to levodopa for years.
How long do people live with PSP?
Average survival is around six to nine years from symptom onset, though the range is wide and some variants progress more slowly. The main threats are falls, swallowing failure with pneumonia, and immobility complications — which is why falls prevention and swallowing surveillance dominate care.
Is there a treatment that slows PSP?
Not yet. Several tau-targeted therapies have been tested and so far none has proven effective in trials, though research continues. Current care — physiotherapy, falls prevention, swallowing management, mood treatment — makes a real difference to safety and quality of life.
More in Letter P
Related
Sources
- Progressive Supranuclear Palsy (MedlinePlus)
- Progressive Supranuclear Palsy — MedlinePlus Genetics (MedlinePlus)
- Progressive Supranuclear Palsy (National Organization for Rare Disorders (NORD))
- Progressive Supranuclear Palsy — Genetic and Rare Diseases Information Center (NIH GARD)
This guide is general information, not medical advice. Rare diseases are individual — diagnosis and treatment depend on your own results, other conditions, and treatment history, and are set by your treating team. Never start, stop, or change a medicine because of something you read here. If you have severe breathlessness, uncontrolled bleeding, confusion, sudden weakness, or thoughts of harming yourself, seek urgent care. Falls prevention and swallowing plans are individual; follow your movement-disorder team's advice.